MetaVia Inc.
MTVA
शेयरों में रैंक
#33010
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
शेयर मूल्य
$1.24
मार्केट कैप
$8.17M
बदलाव (1 दिन)
-1.59%
बदलाव (1 वर्ष)
-23.93%
देश
US
व्यापार MetaVia Inc. (MTVA)
श्रेणी
Healthcare
का बाजार पूंजीकरण MetaVia Inc.(MTVA)
मार्केट कैप: $8.17M
October 2026 में MetaVia Inc. का मार्केट कैप $8.17M है। हमारे डेटा के अनुसार, यह MetaVia Inc. को दुनिया की 33010th सबसे मूल्यवान कंपनी बनाता है। मार्केट कैप किसी सार्वजनिक कंपनी के सभी जारी शेयरों का कुल बाजार मूल्य होता है और इसका उपयोग आमतौर पर कंपनी के मूल्य को मापने के लिए किया जाता है।
MetaVia Inc. का बाजार पूंजीकरण इतिहास 2016 से 2026 तक
MTVA शीर्ष 5 के साथ तुलना में सबसे लोकप्रिय stocks
